Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients
about
A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinomaMolecular biology of lung cancer: clinical implicationsThe Impact of External Factors on the Epigenome: In Utero and over LifetimeEpigenetics in non-small cell lung cancer: from basics to therapeuticsEpigenetics of lung cancerDNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateConcomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokersNeoplasia: Where We Have Been and Where We Are GoingThe role of DNA methylation as biomarkers in the clinical management of lung cancer.Neoplasia: the second decade.Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.Molecular profile of lung cancer in never smokers.Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma.Association between lifestyle factors and CpG island methylation in a cancer-free population.Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.Aberrant gene promoter methylation in sputum from individuals exposed to smoky coal emissionsDifferent patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer.Hypermethylation of CCND2 May Reflect a Smoking-Induced Precancerous Change in the Lung.Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.Expression of anion exchanger 1 sequestrates p16 in the cytoplasm in gastric and colonic adenocarcinoma.Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma.Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation.IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.Maternal smoking as a model for environmental epigenetic changes affecting birthweight and fetal programming.Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer.Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancerCytological examination of pleural cavity lavage accompanied by the study of gene promoter hypermethylation of p16 and O6-methylguanine-DNA-methyltransferase genes in diagnostics of non-small cell lung cancer metastatic changes into pleura.Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokersTowards incorporating epigenetic mechanisms into carcinogen identification and evaluation.DNA methylation in circulating tumour DNA as a biomarker for cancer.CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.Genetic and epigenetic changes in lung carcinoma and their clinical implications.Lung cancer in never smokers.Molecular changes in smoking-related lung cancer.Progress on the role of DNA methylation in aging and longevity.Cigarette smoke-induced failure of apoptosis resulting in enhanced neoplastic transformation in human bronchial epithelial cells.Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans.Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas.
P2860
Q21558626-E6F861E6-E516-4534-A51D-419C9B90222DQ24610335-57AFBC4F-A48B-4317-BB67-37DF400A2E24Q26746703-7A0412B5-7500-4D1E-AAFB-5E237C375BFAQ26749113-A3CA0A34-A851-4D6E-9728-840F29E31FF4Q26996766-EAB43970-3292-400E-99FE-3379E689CB6EQ28386334-C0991341-5BC3-401A-A027-F9607949A85DQ28389551-46E3380B-E406-4B61-8F45-204340A11293Q28395095-F4B71A1D-C989-4927-892A-92E74484790EQ30317739-08445561-0D59-4A54-B769-6EE78A649431Q30484000-B9E76C3E-7755-43C3-BE66-53FBD321037DQ33283634-76DF79E8-5604-4D51-89DF-4F7F5647EDF8Q33696507-178F66D3-6629-4F84-B7C2-3B4F76CDA2F2Q33759346-C8CF60BD-3280-425B-B32C-9C515EB0C0FAQ33886934-99830AF3-A19C-4D8D-AF40-63F68B428E4DQ34103461-B37AD18B-E39C-465C-B910-5341F5955AA2Q34281091-7EF85BBC-D8A1-4397-AF74-76F4C079537AQ34319824-7F842BD2-850A-4BFF-B9EA-8D21840FC6C5Q34960376-878976BB-FCF2-407F-A830-8E81EC6D8FA5Q35925139-9C2BE3D7-B5CB-45EA-8DAD-128560C4D9E2Q36088632-979528AC-3510-4129-9864-DE0B5D359A1AQ36137083-46E99C72-2057-481C-BFFC-9C27FF5014D5Q36178947-9A1C6F62-116C-4CFB-A5E3-A913E19741BEQ36216466-B5C84298-1B4D-42CA-8925-969984FD847FQ36259638-BF0F708D-BA1E-47E3-BAE4-B4C5488D6289Q36464478-84E124DA-57D6-4309-97E6-A0C769E55FB1Q36606069-731E95CF-D9A5-4DFA-A37B-C483A273119BQ36791714-B294F94B-C350-4A48-9EE3-D46A3367D49DQ36942585-2947E665-6133-4FED-9FBD-1736EDBBE8F5Q37037246-BAE662D2-C0A4-44E7-93BB-D76FDD42F5B8Q37151661-DD16546C-85E6-4493-A709-1C0D30FD4F53Q37280956-66258DF4-92E1-421E-A9CE-9E62B9F7252CQ37633163-46A343AD-3898-40B3-9F7C-31F7F20FDD82Q37855515-E5E17D6A-DB11-4471-B76A-BCA9D02AC182Q37944937-C2CE6591-9393-4503-BE50-AC525A3290DFQ37963519-905BE99A-B121-4958-87B0-5B8623E39391Q38794713-0DDFF419-931E-42B8-B89D-4429780C88BBQ39320678-A6133AC8-E7C5-4CDF-B68D-E5D99B95A98DQ40089637-D0DF72C7-0323-4761-B945-523D31A5FB4EQ41979469-A8A78BAE-65D0-46BC-83CC-0F8E1C617577Q44029916-73C4B326-518A-498F-AEA1-3A5D46B133D7
P2860
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Aberrant promoter methylation ...... r-smoking lung cancer patients
@ast
Aberrant promoter methylation ...... r-smoking lung cancer patients
@en
type
label
Aberrant promoter methylation ...... r-smoking lung cancer patients
@ast
Aberrant promoter methylation ...... r-smoking lung cancer patients
@en
prefLabel
Aberrant promoter methylation ...... r-smoking lung cancer patients
@ast
Aberrant promoter methylation ...... r-smoking lung cancer patients
@en
P2093
P2860
P356
P1433
P1476
Aberrant promoter methylation ...... r-smoking lung cancer patients
@en
P2093
James D Luketich
Jill M Siegfried
Phouthone Keohavong
P2860
P356
10.1593/NEO.05586
P577
2006-01-01T00:00:00Z